MedPath
NMPA Approval

xiaoyanlidan tablet

国药准字Z44021102

April 15, 2021

国药准字Z44021102

Drug Information

消炎利胆片

片剂

中药

April 15, 2021

Company Information

Applicant Company

深圳市罗湖区莲塘鹏基工业区704栋

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

消炎利胆片 - NMPA 批准文号 | MedPath